A bill approved by the Alabama Senate sets a $10 drug dispensing fee for pharmacists while also seeking to regulate the ...

CVS faces pressures from rising medical costs, but promising guidance, stable finances, and low valuations suggest strong ...

CVS Health is a BUY. Undervalued with growth potential, it outshines competitors despite sector challenges. See more on CVS ...

A proposed Arkansas bill targeting pharmacy benefit managers is seeing some concerns and pushback. LITTLE ROCK, Ark. — CVS Health has been pushing back against a piece of Arkansas legislation that ...

It’s why Webb, of Rochester, is fighting for the passage of Indiana Senate Bill 140. The bill, which passed the Indiana ...

Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of ...

If you are looking for a stock that has a solid history of beating earnings estimates and is in a good position to maintain ...

Federal Trade Commission Chair Andrew Ferguson has reversed course on his decision to recuse himself from the agency's legal ...

Residents of the Mount Washington neighborhood will no longer be able to pick up their prescriptions right next door as a ...

A House panel Wednesday approved a bill aimed at preventing pharmacy benefit managers from holding a permit to operate a drug store in Arkansas. The Federal Trade Commission released an interim report ...

CVS Health Co. (NYSE:CVS – Get Free Report) has been assigned an average rating of “Moderate Buy” from the twenty-one research firms that are covering the firm, MarketBeat reports. Three equities ...